Markets:

Overview

News

Currencies

International

Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

166.82 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

24 25 Next >

3 Medical Technology Stocks Outperforming in 2025

June 09, 2025

Three med-tech stocks, TransMedics, Insulet, and GRAIL, are outperforming the market and their sector while forming bullish technical patterns.

Via MarketBeat

What's going on in today's session: S&P500 movers ↗

June 06, 2025

Curious about the S&P500 stocks that are in motion on Friday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

Friday's session: top gainers and losers in the S&P500 index ↗

June 06, 2025

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday.

Via Chartmill

Here's How Much $100 Invested In Insulet 15 Years Ago Would Be Worth Today ↗

May 28, 2025

Via Benzinga

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

3 Reasons Investors Love Insulet (PODD)

June 05, 2025

While the broader market has struggled with the S&P 500 down 1.8% since December 2024, Insulet has surged ahead as its stock price has climbed by 18.9% to $318.02 per share. This was partly thanks to...

Via StockStory

Topics Stocks

Q1 Patient Monitoring Earnings: Insulet (NASDAQ:PODD) Earns Top Marks

June 04, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Insulet (NASDAQ:PODD) and its peers.

Via StockStory

Topics Artificial Intelligence

Goldman Sachs Bullish On Dexcom And Insulet As Diabetes Tech Surges ↗

June 02, 2025

Goldman Sachs forecasts strong growth for diabetes tech, backing Dexcom and Insulet while rating Tandem and Beta Bionics as Neutral.

Via Benzinga

INSULET CORP (NASDAQ:PODD) – A Strong Growth Stock with Technical Breakout Potential ↗

June 02, 2025

INSULET CORP (NASDAQ:PODD) shows strong growth fundamentals and a bullish technical pattern, making it a stock worth watching for investors seeking growth opportunities.

Via Chartmill

1 Surging Stock with Exciting Potential and 2 to Question

June 02, 2025

Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage...

Via StockStory

Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

May 23, 2025

From Insulet Corporation

Via Business Wire

5 Analysts Assess Insulet: What You Need To Know ↗

May 22, 2025

Via Benzinga

INSULET CORP (NASDAQ:PODD) – A Strong Growth Stock Meeting Minervini’s Trend Template ↗

May 20, 2025

INSULET CORP (NASDAQ:PODD) meets Minervini’s Trend Template with strong technicals and high growth fundamentals, making it a candidate for momentum investors.

Via Chartmill

The End Of The Diabetes Industry? This Small Cap Could Upend The Business Models of Pharma Giants ↗

May 19, 2025

is it the end of the diabetes industry? Here's a small cap that could upend the business models of pharma giants...

Via Benzinga

Insulet Surges on Q1 Beat, Emerges as a Top S&P 500 Performer

May 14, 2025

Insulet's earnings and upgraded guidance recently propelled its stock to S&P 500 leadership, showcasing strong execution in the diabetes care market.

Via MarketBeat

Topics Stocks

1 Mid-Cap Stock to Target This Week and 2 to Avoid

May 14, 2025

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with...

Via StockStory

$1000 Invested In Insulet 15 Years Ago Would Be Worth This Much Today ↗

May 13, 2025

Via Benzinga

Insulet Announces Publication of 2024 Sustainability Report

May 13, 2025

From Insulet Corporation

Via Business Wire

The Trade Desk, Walt Disney, And Hims & Hers Health Are Among Top 11 Large-Cap Gainers Last Week (May 5-May 9): Are The Others In Your Portfolio? ↗

May 11, 2025

Top-performing large-cap stocks last week: TTD, HIMS, PODD, FTAI, ULS, UI, ROK, TOST, DIS, MCHP, and ARMK. Analysts raised price forecasts.

Via Benzinga

Stay informed with the top movers within the S&P500 index on Friday. ↗

May 09, 2025

Get insights into the S&P500 index performance on Friday. Explore the top gainers and losers within the S&P500 index in today's session.

Via Chartmill

Why Insulet (PODD) Stock Is Trading Up Today

May 09, 2025

Shares of insulin delivery company Insulet Corporation (NASDAQ:PODD) jumped 20.7% in the afternoon session after the company reported strong first quarter 2025 results which significantly beat...

Via StockStory

What's going on in today's session: S&P500 movers ↗

May 09, 2025

Let's delve into the developments on the US markets in the middle of the day on Friday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Via Chartmill

Stocks Slip As Gold Rebounds To $3,330, Bitcoin Holds $102,000: What's Driving Markets Friday? ↗

May 09, 2025

Wall Street traded slightly lower by midday Friday, as investors adopted a wait-and-see stance ahead of a potential trade breakthrough, with high-stakes negotiations between U.S. officials—led by...

Via Benzinga

Insulet Posts Strong Q1 Results, Raises Forecasts On Momentum In US And Abroad ↗

May 09, 2025

Insulet beat Q1 expectations with $569 million in revenue and raised its 2025 outlook as global Omnipod adoption drives double-digit growth.

Via Benzinga

Wondering what's happening in today's S&P500 pre-market session? ↗

May 09, 2025

Pre-market stock analysis of S&P500 stocks on 2025-05-09: top gainers and losers in today's session.

Via Chartmill

Insulet Posts Upbeat Earnings, Joins Trade Desk, TransMedics Group, Tesla And Other Big Stocks Moving Higher On Friday ↗

May 09, 2025

Via Benzinga

Which S&P500 stocks are showing activity after the closing bell on Thursday? ↗

May 08, 2025

After the closing bell on Thursday, let's take a glimpse of the US markets and explore the top S&P500 gainers and losers in today's after-hours session.

Via Chartmill

Insulet’s (NASDAQ:PODD) Q1: Strong Sales, Stock Soars

May 08, 2025

Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 28.8% year on year to $569 million. On top of that, next...

Via StockStory

Insulet Jumps After Beating Quarterly Forecasts, Raising 2025 Expectations ↗

May 08, 2025

Insulet stock jumped late Thursday after the insulin pump-maker beat first-quarter forecasts and raised its sales outlook.

Via Investor's Business Daily

Insulet Reports First Quarter 2025 Revenue Increase of 29% Year-Over-Year (30% Constant Currency1)

May 08, 2025

From Insulet Corporation

Via Business Wire

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

24 25 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.